Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiya Inada

Showing results (181-190 of 219) with videos related to

Pageof 22
Sort By:
The American Journal of Psychiatry|July 4, 2007
Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosisDaisuke Matsuzawa, Kenji Hashimoto, Ryosuke Miyatake, et al.
Scientific Reports|October 24, 2015
Association study of BCL9 gene polymorphism rs583583 with schizophrenia and negative symptoms in Japanese populationHiroki Kimura, Satoshi Tanaka, Itaru Kushima, et al.
Neuroscience Letters|September 18, 2012
An evaluation of polymorphisms in casein kinase 1 delta and epsilon genes in major psychiatric disordersShinji Matsunaga, Masashi Ikeda, Taro Kishi, et al.
Archives of General Psychiatry|March 5, 2008
Genome-wide association for methamphetamine dependence: convergent results from 2 samplesGeorge R Uhl, Tomas Drgon, Qing-Rong Liu, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 26, 2009
Association analyses between brain-expressed fatty-acid binding protein (FABP) genes and schizophrenia and bipolar disorderYoshimi Iwayama, Eiji Hattori, Motoko Maekawa, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 19, 2011
Association of SNPs linked to increased expression of SLC1A1 with schizophreniaYasue Horiuchi, Syuhei Iida, Minori Koga, et al.
Psychiatria Danubina|August 16, 2020
Relationship Between Body Mass Index and Extrapyramidal Symptoms in Asian Patients with Schizophrenia: The Research on Asian Psychotropic Prescription Patterns for Antipsychotics (REAP-AP)Seon-Cheol Park, Adarsh Tripathi, Ajit Avasthi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 26, 2007
A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcriptionTetsuo Ohnishi, Kazuo Yamada, Hisako Ohba, et al.
Biological Psychiatry|December 15, 2012
A population-specific uncommon variant in GRIN3A associated with schizophreniaAtsushi Takata, Yoshimi Iwayama, Yasuhisa Fukuo, et al.
Plos One|June 1, 2012
Common variants in MAGI2 gene are associated with increased risk for cognitive impairment in schizophrenic patientsTakayoshi Koide, Masahiro Banno, Branko Aleksic, et al.
Pageof 22

Showing results (181-190 of 219) with videos related to

Sort By:
Pageof 22
The American Journal of Psychiatry|July 4, 2007
Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosisDaisuke Matsuzawa, Kenji Hashimoto, Ryosuke Miyatake, et al.
Scientific Reports|October 24, 2015
Association study of BCL9 gene polymorphism rs583583 with schizophrenia and negative symptoms in Japanese populationHiroki Kimura, Satoshi Tanaka, Itaru Kushima, et al.
Neuroscience Letters|September 18, 2012
An evaluation of polymorphisms in casein kinase 1 delta and epsilon genes in major psychiatric disordersShinji Matsunaga, Masashi Ikeda, Taro Kishi, et al.
Archives of General Psychiatry|March 5, 2008
Genome-wide association for methamphetamine dependence: convergent results from 2 samplesGeorge R Uhl, Tomas Drgon, Qing-Rong Liu, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 26, 2009
Association analyses between brain-expressed fatty-acid binding protein (FABP) genes and schizophrenia and bipolar disorderYoshimi Iwayama, Eiji Hattori, Motoko Maekawa, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 19, 2011
Association of SNPs linked to increased expression of SLC1A1 with schizophreniaYasue Horiuchi, Syuhei Iida, Minori Koga, et al.
Psychiatria Danubina|August 16, 2020
Relationship Between Body Mass Index and Extrapyramidal Symptoms in Asian Patients with Schizophrenia: The Research on Asian Psychotropic Prescription Patterns for Antipsychotics (REAP-AP)Seon-Cheol Park, Adarsh Tripathi, Ajit Avasthi, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 26, 2007
A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcriptionTetsuo Ohnishi, Kazuo Yamada, Hisako Ohba, et al.
Biological Psychiatry|December 15, 2012
A population-specific uncommon variant in GRIN3A associated with schizophreniaAtsushi Takata, Yoshimi Iwayama, Yasuhisa Fukuo, et al.
Plos One|June 1, 2012
Common variants in MAGI2 gene are associated with increased risk for cognitive impairment in schizophrenic patientsTakayoshi Koide, Masahiro Banno, Branko Aleksic, et al.
Pageof 22